Correction to Lancet Oncol 2015; 16: 60, 61. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study.
Lancet Oncol
; 16(4): e158, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25846094
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2015
Document type:
Article